- Achillion Pharmaceuticals, Inc. stock price today and history
Achillion Pharmaceuticals, Inc. (ACHN) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Achillion Pharmaceuticals, Inc. stock price
Achillion Pharmaceuticals, Inc. latest news:
BRIEF-Achillion announces termination of worldwide collaboration for hepatitis c with Janssen
Achillion Pharmaceuticals Inc(ACHN). * Achillion announces termination of worldwide collaboration for hepatitis c with Janssen Further company coverage:
Achillion shares rally as blood disorder treatment shows promise
Shares of Achillion Pharmaceuticals Inc. surged in the extended session Tuesday after the drug developer met expectations for second-quarter results and said early results of a blood disorder treatment look promising. Achillion shares rallied 33% to $5.35 after hours. The company said four patients so far enrolled in a mid-stage clinical study of ACH-4471, meant to treat paroxysmal nocturnal hemoglobinuria, were responding well to the drug. Paroxysmal nocturnal hemoglobinuria is a rare, acquired condition where the body's immune system destroys red blood cells in error. Achillion also reported a second-quarter loss of $22.5 million, or 16 cents a share, compared with a loss of $18.5 million, or 14 cents a share, in the year-ago period. Analysts surveyed by FactSet had forecast a loss of 16 cents a share.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
ACI Worldwide, Inc.ACIW
Acorda Therapeutics, Inc.ACOR
Actions Semiconductor Co., Ltd.ACTS
Active Power, Inc.ACPW
Activision Blizzard, IncATVI
Acura Pharmaceuticals, Inc.ACUR
Adamas Pharmaceuticals, Inc.ADMS